...
首页> 外文期刊>Medical and Pediatric Oncology: The Official Journal of the American Association for Cancer Education >Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials.
【24h】

Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials.

机译:治疗儿童急性淋巴细胞白血病后,运动神经通路功能受损:一项具有运动诱发电位的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The objective was to evaluate whether motor nervous pathways are affected when patients are treated for childhood acute lymphoblastic leukemia (ALL). PROCEDURE: Thirty-two children with ALL were studied at the end of treatment by means of motor evoked potentials (MEPs) elicited by magnetic stimulation (MS) transcranially and peripherally and underwent a detailed neurological examination. Thirty-two healthy children matched with them for age, sex, and height served as a control group. RESULTS: The latencies of the MEPs were significantly prolonged along the entire motor nervous pathway in the patients with ALL compared with the healthy controls, indicating demyelination in the thick motor fibres. The MEP amplitudes of the distal extremities elicited by stimulation at the brachial plexus and LV spinal level were significantly lowered in the patients treated for ALL, also indicating anatomical or functional loss of descending motor fibres and/or muscle fibres. The MEP amplitudes elicited by cortical MS showed wider variation and no clear abnormalities were found. Neurological signs and symptoms were common after treatment: 41% of the patients had depressed deep tendon reflexes, 31% had fine motor difficulties and 63% gross motor difficulties, and 34% had dysdiadochokinesia. The conduction delay within the peripheral nerve was related to the post-therapeutic interval after administration of vincristine and the lesions within the CNS to the number of injections of intrathecal methotrexate. CONCLUSIONS: The present results show adverse effects of the ALL treatment on the entire motor nervous pathways. In our experience, the measurement of MEPs by MS provides an objective, painless, and practical tool for assessing the treatment-related neurotoxicity in both the CNS and the peripheral nerves. These disturbances in the motor nervous pathways at the end of treatment raise the question of the long-term effects of ALL treatment on the motor nerve tracts, and have led us to employ MEPs to study these effects in long-term survivors of ALL. Copyright 2001 Wiley-Liss, Inc.
机译:背景:目的是评估当治疗儿童急性淋巴细胞白血病(ALL)时,运动神经通路是否受到影响。程序:在治疗结束时对32例ALL儿童进行了研究,方法是通过经颅和外周磁刺激(MS)诱发的运动诱发电位(MEP)进行详细的神经学检查。年龄,性别和身高相匹配的三十二名健康儿童作为对照组。结果:与健康对照组相比,ALL患者的MEP沿整个运动神经通路的潜伏期显着延长,这表明较厚的运动纤维脱髓鞘。在接受ALL治疗的患者中,臂丛神经和LV脊柱水平刺激引起的远端四肢MEP幅度显着降低,也表明运动肌纤维和/或肌纤维下降的解剖或功能丧失。皮质MS诱发的MEP振幅显示出较大的变化,未发现明显异常。治疗后的神经系统症状和体征很常见:41%的患者深部肌腱反射抑制,31%的患者出现精细运动障碍和63%的总体运动障碍,以及34%的运动障碍性神经痛。周围神经内的传导延迟与长春新碱给药后的治疗间隔以及CNS内的病变与鞘内注射甲氨蝶呤的次数有关。结论:目前的结果表明ALL治疗对整个运动神经通路的不利影响。根据我们的经验,MS对MEP的测量为评估CNS和周围神经中与治疗相关的神经毒性提供了一种客观,无痛且实用的工具。在治疗结束时,运动神经通路的这些紊乱引起了ALL治疗对运动神经束的长期影响的问题,并导致我们聘请MEPs对ALL的长期幸存者进行研究。版权所有2001 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号